Advisory Services Network’s Aerie Pharmaceuticals AERI Stock Holding History

Advisory Services Network’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-51	Closed	-$1K	–	3541
2021 Q2	$1K	Buy	+51	New	+$875	﹤0.01%	3559
2021 Q1	–	Sell	-51	Closed	-$1K	–	3203
2020 Q4	$1K	Buy	+51	New	+$616	﹤0.01%	3235
2020 Q1	–	Sell	-261	Closed	-$6K	–	3372
2019 Q4	$6K	Buy	+261	New	+$5.41K	﹤0.01%	2582
2015 Q3	–	Sell	-300	Closed	-$5K	–	1615
2015 Q2	$5K	Buy	+300	New	+$5.5K	﹤0.01%	1100

Other funds holding AERI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Advisory Services Network's AERI Position: Q3 2021 in Review

Advisory Services Network sold out of Aerie Pharmaceuticals (AERI) in Q3 2021, closing a stake of 51 shares — an estimated $1K sold.

Advisory Services Network first reported a position in AERI in Q2 2015 and held it in 4 quarters. The position peaked at $6K in Q4 2019. 137 funds tracked by Wall St. Rank hold AERI as of Q3 2021.

Advisory Services Network reported no remaining Aerie Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
Advisory Services Network sold 51 Aerie Pharmaceuticals shares in Q3 2021, an estimated $1K.
Advisory Services Network first reported a position in Aerie Pharmaceuticals in Q2 2015 and held it in 4 quarters.
Advisory Services Network's Aerie Pharmaceuticals position peaked at $6K in Q4 2019.
137 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q3 2021.

Based on Advisory Services Network's 13F filing for Q3 2021, filed 5 Nov 2021.